US4060082A
(en)
|
1976-08-16 |
1977-11-29 |
Mpl, Inc. |
Dual-ingredient medication dispenser
|
US4500513A
(en)
|
1979-05-15 |
1985-02-19 |
Miles Laboratories, Inc. |
Influenza vaccine production in liquid cell culture
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
JPS62201573A
(ja)
|
1986-02-27 |
1987-09-05 |
Shionogi & Co Ltd |
家禽用インフルエンザワクチン
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
AU631377B2
(en)
|
1988-08-25 |
1992-11-26 |
Liposome Company, Inc., The |
Affinity associated vaccine
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
HU212924B
(en)
*
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
CA2104782C
(en)
|
1991-03-01 |
2001-08-07 |
John F. Gerster |
1-substituted, 2-substituted 1h-imidazo-[4,5-c]quinolin-4- amines
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
JPH0614756Y2
(ja)
|
1991-06-26 |
1994-04-20 |
株式会社アルテ |
組み立て式の2室式容器兼用注射器
|
US5936076A
(en)
|
1991-08-29 |
1999-08-10 |
Kirin Beer Kabushiki Kaisha |
αgalactosylceramide derivatives
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
MY111880A
(en)
|
1992-03-27 |
2001-02-28 |
Smithkline Beecham Biologicals S A |
Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
JP3755890B2
(ja)
|
1992-06-25 |
2006-03-15 |
スミスクライン・ビーチャム・バイオロジカルス(ソシエテ・アノニム) |
アジュバント含有ワクチン組成物
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
ATE204762T1
(de)
|
1993-03-23 |
2001-09-15 |
Smithkline Beecham Biolog |
3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
|
WO1995002597A1
(en)
|
1993-07-15 |
1995-01-26 |
Minnesota Mining And Manufacturing Company |
IMIDAZO[4,5-c]PYRIDIN-4-AMINES
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
ES2370937T3
(es)
|
1993-09-13 |
2011-12-23 |
Protein Sciences Corporation |
Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
|
US5762939A
(en)
*
|
1993-09-13 |
1998-06-09 |
Mg-Pmc, Llc |
Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
|
AU5543294A
(en)
|
1993-10-29 |
1995-05-22 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5824536A
(en)
|
1994-08-23 |
1998-10-20 |
St. Jude Children's Research Hospital |
Influenza virus replicated in mammalian cell culture and vaccine production
|
US5496284A
(en)
|
1994-09-27 |
1996-03-05 |
Waldenburg; Ottfried |
Dual-chamber syringe & method
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
EP2290053A1
(de)
|
1994-11-10 |
2011-03-02 |
Baxter Healthcare S.A. |
Verfahren zur Herstellung von Influenzaviren in protein-freiem Zellkulturmedium
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
GB9503863D0
(en)
|
1995-02-25 |
1995-04-19 |
Smithkline Beecham Biolog |
Vaccine compositions
|
GB9620795D0
(en)
|
1996-10-05 |
1996-11-20 |
Smithkline Beecham Plc |
Vaccines
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
DE19612967A1
(de)
|
1996-04-01 |
1997-10-02 |
Behringwerke Ag |
Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
|
DE19612966B4
(de)
|
1996-04-01 |
2009-12-10 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
|
WO1998001174A1
(fr)
|
1996-07-05 |
1998-01-15 |
Debiotech S.A. |
Seringue a chambre double permettant le melange de deux produits avant leur injection
|
EP0930893B1
(de)
|
1996-10-11 |
2005-04-13 |
The Regents of The University of California |
Immunostimulierende oligonucleotidekonjugate
|
AT405939B
(de)
|
1997-02-24 |
1999-12-27 |
Immuno Ag |
Verfahren zur inaktivierung von lipidumhüllten viren
|
PT1005368E
(pt)
|
1997-03-10 |
2009-11-19 |
Coley Pharm Gmbh |
Utilização de ácidos nucleicos contendo dinucleótidos cpg não metilados em combinação com alúmen como adjuvante
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
TW570803B
(en)
|
1997-04-09 |
2004-01-11 |
Duphar Int Res |
Influenza vaccine
|
AU7126998A
(en)
|
1997-04-16 |
1998-11-11 |
Connaught Laboratories Inc. |
Anti-influenza compositions supplemented with neuraminidase
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
GB9711990D0
(en)
*
|
1997-06-11 |
1997-08-06 |
Smithkline Beecham Biolog |
Vaccine
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
DE69815692T2
(de)
|
1997-09-05 |
2004-04-29 |
Glaxosmithkline Biologicals S.A. |
Öl in wasser emulsionen mit saponinen
|
GB9718901D0
(en)
|
1997-09-05 |
1997-11-12 |
Smithkline Beecham Biolog |
Vaccine
|
US5971953A
(en)
|
1998-01-09 |
1999-10-26 |
Bachynsky; Nicholas |
Dual chamber syringe apparatus
|
WO1999017820A1
(en)
|
1997-10-03 |
1999-04-15 |
Texas Pharmaceuticals, Inc. |
Improved dual chamber syringe apparatus
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
WO1999027961A1
(en)
|
1997-12-02 |
1999-06-10 |
Powderject Vaccines, Inc. |
Transdermal delivery of particulate vaccine compositions
|
US6782510B1
(en)
|
1998-01-27 |
2004-08-24 |
John N. Gross |
Word checking tool for controlling the language content in documents using dictionaries with modifyable status fields
|
IL138000A0
(en)
|
1998-04-09 |
2001-10-31 |
Smithkline Beecham Biolog |
Adjuvant compositions
|
US6630161B1
(en)
|
1998-05-07 |
2003-10-07 |
Ribi Immunochem Research, Inc. |
Adjuvant composition and methods for its use
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
DE19835749C1
(de)
|
1998-08-07 |
2000-02-03 |
Dieter Perthes |
Fertig-Spritze für nicht-stabile Arzneimittel
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
AT408615B
(de)
*
|
1998-09-15 |
2002-01-25 |
Immuno Ag |
Neue influenzavirus-impfstoffzusammensetzung
|
CA2347099C
(en)
|
1998-10-16 |
2014-08-05 |
Smithkline Beecham Biologicals S.A. |
Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
|
US20030130212A1
(en)
|
1999-01-14 |
2003-07-10 |
Rossignol Daniel P. |
Administration of an anti-endotoxin drug by intravenous infusion
|
US6551600B2
(en)
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
ATE276199T1
(de)
|
1999-02-03 |
2004-10-15 |
Biosante Pharmaceuticals Inc |
Methoden zur herstellung von therapeutische kalzium-phosphat partikeln
|
WO2000050006A2
(en)
*
|
1999-02-26 |
2000-08-31 |
Chiron Corporation |
Microemulsions with adsorbed macromoelecules and microparticles
|
ES2308069T3
(es)
|
1999-03-26 |
2008-12-01 |
Vical Incorporated |
Composiciones adyuvantes para realzar inmunorespuestas a las vacunas polinucleotido-basadas.
|
PT1185615E
(pt)
|
1999-04-06 |
2007-10-04 |
Wisconsin Alumni Res Found |
''vírus da influenza recombinantes para vacinas e tratamento genético''
|
IL145982A0
(en)
*
|
1999-04-19 |
2002-07-25 |
Smithkline Beecham Biolog |
Vaccines
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
ATE353370T1
(de)
|
1999-07-14 |
2007-02-15 |
Sinai School Medicine |
In vitro-rekonstitution von segmentierten, negativstrang-rna-viren
|
CN1391483A
(zh)
|
1999-09-24 |
2003-01-15 |
史密丝克莱恩比彻姆生物有限公司 |
作为佐剂的聚氧乙烯脱水山梨醇酯和辛苯昔醇组合及其在疫苗中的应用
|
AR025749A1
(es)
|
1999-09-24 |
2002-12-11 |
Smithkline Beecham Biolog |
Vacunas
|
ES2293923T3
(es)
|
1999-09-24 |
2008-04-01 |
Glaxosmithkline Biologicals S.A. |
Vacuna intranasal contra el virus influenza.
|
DK1221955T3
(da)
|
1999-09-25 |
2006-01-30 |
Univ Iowa Res Found |
Immunstimulerende nukleinsyre
|
GB9923176D0
(en)
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
US20040109874A1
(en)
|
1999-11-10 |
2004-06-10 |
Powderject Vaccines, Inc. |
Induction of mucosal immunity by vaccination via the skin route
|
EP1311288A1
(de)
|
2000-01-20 |
2003-05-21 |
Ottawa Health Research Institute |
Immunstimulierende nukleinsäuren zur induktion einer th-2 immunreaktion
|
CA2401117C
(en)
|
2000-03-03 |
2010-06-29 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
|
CA2406949A1
(fr)
|
2000-04-26 |
2001-11-01 |
Roger Kravtzoff |
Utilisation de vecteurs particulaires dans l'immunomodulation
|
PT1317559E
(pt)
|
2000-04-28 |
2009-02-12 |
St Jude Childrens Res Hospital |
Sistema de transfecção de adn para a produção de vírus infecciosos de arn de cadeia negativa
|
FR2808803B1
(fr)
|
2000-05-11 |
2004-12-10 |
Agronomique Inst Nat Rech |
Cellules es modifiees et gene specifique de cellules es
|
PT1313734E
(pt)
|
2000-09-01 |
2010-02-09 |
Novartis Vaccines & Diagnostic |
Derivados aza heterocíclicos e sua utilização terapêutica
|
EP1317442B1
(de)
|
2000-09-11 |
2005-11-16 |
Chiron Corporation |
Chinolinonderivate als tyrosin-kinase inhibitoren
|
AUPR007600A0
(en)
*
|
2000-09-13 |
2000-10-05 |
Kajlich, Anti |
Equipment for faster swimming pools
|
KR100865706B1
(ko)
|
2000-09-26 |
2008-10-28 |
이데라 파마슈티칼즈, 인코포레이티드 |
화학적인 위치 변화에 의해 면역자극 올리고누클레오티드유사체의 면역자극 활성을 조절하는 방법
|
GB0024089D0
(en)
|
2000-10-02 |
2000-11-15 |
Smithkline Beecham Biolog |
Novel compounds
|
HU229642B1
(en)
|
2000-10-18 |
2014-03-28 |
Glaxosmithkline Beecham Biolog S A |
Vaccines against cancers
|
GB0025577D0
(en)
|
2000-10-18 |
2000-12-06 |
Smithkline Beecham Biolog |
Vaccine
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
UA75622C2
(en)
|
2000-12-08 |
2006-05-15 |
3M Innovative Properties Co |
Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
US7018638B2
(en)
|
2000-12-19 |
2006-03-28 |
Wyeth |
Mycoplasma hyopneumoniae bacterin vaccine
|
AU2002254901A1
(en)
|
2001-02-23 |
2002-10-03 |
Smithkline Beecham Biologicals S.A. |
Influenza vaccine formulations for intradermal delivery
|
US20040096463A1
(en)
|
2001-02-23 |
2004-05-20 |
Nathalie Garcon |
Novel vaccine
|
JP4137640B2
(ja)
|
2001-03-09 |
2008-08-20 |
アイディー バイオメディカル コーポレイション オブ ケベック |
新規プロテオソーム−リポサッカリドワクチンアジュバント
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US7361352B2
(en)
|
2001-08-15 |
2008-04-22 |
Acambis, Inc. |
Influenza immunogen and vaccine
|
DE10144903A1
(de)
|
2001-09-12 |
2003-03-27 |
Chiron Behring Gmbh & Co |
Vermehrung von Viren in Zellkultur
|
DE10144906B4
(de)
|
2001-09-12 |
2013-11-28 |
Novartis Vaccines And Diagnostics Gmbh |
Verfahren zur großtechnischen Herstellung von Impfstoffen
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
FR2832423B1
(fr)
|
2001-11-22 |
2004-10-08 |
Vivalis |
Systeme d'expression de proteines exogenes dans un systeme aviaire
|
UA79764C2
(en)
|
2001-11-27 |
2007-07-25 |
Anadys Pharmaceuticals Inc |
3-?-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
|
US7321033B2
(en)
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
FR2836924B1
(fr)
|
2002-03-08 |
2005-01-14 |
Vivalis |
Lignees de cellules aviaires utiles pour la production de substances d'interet
|
US6861410B1
(en)
*
|
2002-03-21 |
2005-03-01 |
Chiron Corporation |
Immunological adjuvant compositions
|
IL164302A0
(en)
|
2002-03-29 |
2005-12-18 |
Chiron Corp |
Substituted benzazoles and use thereof as raf kinase inhibitors
|
JP2005531599A
(ja)
|
2002-05-29 |
2005-10-20 |
スリーエム イノベイティブ プロパティズ カンパニー |
イミダゾ[4,5−c]ピリジン−4−アミンのための方法
|
AU2003251518B2
(en)
|
2002-06-13 |
2009-07-02 |
New York University |
Synthetic C-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
|
AU2003268184A1
(en)
|
2002-08-23 |
2004-03-11 |
Chiron Corporation |
Pyrrole based inhibitors of glycogen synthase kinase 3
|
CA2511646A1
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
CA2513655C
(en)
|
2003-01-21 |
2011-11-22 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
GB0301554D0
(en)
|
2003-01-23 |
2003-02-26 |
Molecularnature Ltd |
Immunostimulatory compositions
|
WO2004084937A1
(en)
|
2003-03-24 |
2004-10-07 |
Intercell Ag |
Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses
|
CA2520124A1
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of benzazole compounds for immunopotentiation
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
SI1651265T1
(sl)
|
2003-07-24 |
2008-10-31 |
Merial Ltd |
Formulacije cepiva, ki obsegajo emulzijo olje v vodi
|
RU2236257C1
(ru)
|
2003-09-15 |
2004-09-20 |
Косяков Константин Сергеевич |
Синтетический иммуноген для терапии и профилактики злоупотреблений наркотическими и психоактивными веществами
|
US7771726B2
(en)
|
2003-10-08 |
2010-08-10 |
New York University |
Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
|
EP1528101A1
(de)
|
2003-11-03 |
2005-05-04 |
ProBioGen AG |
Immortalisierte Vogel-Zelllinien für die Produktion von Viren
|
US8673634B2
(en)
|
2003-11-13 |
2014-03-18 |
Massachusetts Eye & Ear Infirmary |
Method for the treatment of hearing loss
|
EP1550458A1
(de)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergisitische liposomale Adjuvantien
|
US20080254065A1
(en)
*
|
2004-03-09 |
2008-10-16 |
Chiron Corporation |
Influenza Virus Vaccines
|
US20080234632A1
(en)
|
2004-03-23 |
2008-09-25 |
Mitsuru Hasegawa |
Pre-Filled Syringe
|
JP2007531768A
(ja)
|
2004-03-31 |
2007-11-08 |
ニューヨーク・ユニバーシティ |
感染症、癌および自己免疫疾患を治療するための新規な合成c−糖脂質、その合成および使用
|
KR20110132416A
(ko)
|
2004-04-05 |
2011-12-07 |
화이자 프로덕츠 인코포레이티드 |
미세유체화된 수중유 유화액 및 백신 조성물
|
WO2005113756A1
(en)
|
2004-05-14 |
2005-12-01 |
Glaxosmithkline Biologicals S.A. |
Method
|
RU2006145303A
(ru)
|
2004-05-20 |
2008-06-27 |
АйДи БАЙОМЕДИКАЛ КОРПОРЕЙШН (CA) |
Способ получения противогриппозной вакцины
|
CA2565500A1
(en)
|
2004-05-28 |
2005-12-15 |
Glaxosmithkline Biologicals S.A. |
Vaccine compositions comprising virosomes and a saponin adjuvant
|
EP2277595A3
(de)
|
2004-06-24 |
2011-09-28 |
Novartis Vaccines and Diagnostics, Inc. |
Verbindungen zur Immunopotenzierung
|
DE102004032251B4
(de)
|
2004-07-03 |
2008-05-29 |
Daimler Ag |
Vorrichtung zur Abscheidung von Wasser und zur Ausfilterung von Verunreinigungen
|
DE602005024827D1
(de)
|
2004-09-09 |
2010-12-30 |
Novartis Vaccines & Diagnostic |
Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen
|
US20070292386A9
(en)
|
2004-12-02 |
2007-12-20 |
Campbell Robert L |
Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents
|
AU2005322353B2
(en)
|
2004-12-23 |
2011-09-01 |
Medimmune, Llc |
Non-tumorigenic MDCK cell line for propagating viruses
|
RU2435855C2
(ru)
|
2004-12-24 |
2011-12-10 |
Солвей Байолоджикалз Б.В. |
Способ продуцирования репликативной частицы вируса гриппа, композиция клеток (варианты), композиция клеточной культуры и ее применение
|
AU2006226458B2
(en)
*
|
2005-03-23 |
2012-08-30 |
Glaxosmithkline Biologicals S.A. |
Novel composition
|
FR2884255B1
(fr)
|
2005-04-11 |
2010-11-05 |
Vivalis |
Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
|
US7691368B2
(en)
|
2005-04-15 |
2010-04-06 |
Merial Limited |
Vaccine formulations
|
AR054822A1
(es)
|
2005-07-07 |
2007-07-18 |
Sanofi Pasteur |
Emulsion inmuno adyuvante
|
US7925378B2
(en)
|
2005-07-11 |
2011-04-12 |
Brooks Automation, Inc. |
Process apparatus with on-the-fly workpiece centering
|
US7425336B2
(en)
*
|
2005-08-25 |
2008-09-16 |
Mevial Limited |
Canine influenza vaccines
|
US7384642B2
(en)
*
|
2005-08-25 |
2008-06-10 |
Merial Limited |
Canine influenza vaccines
|
NZ568212A
(en)
*
|
2005-11-04 |
2012-03-30 |
Novartis Vaccines & Diagnostic |
Changing Th1/Th2 balance in split influenza vaccines with adjuvants
|
EP1957104B1
(de)
*
|
2005-11-04 |
2012-03-21 |
Novartis Vaccines and Diagnostics S.r.l. |
Extemporär auf aluminium-adjuvantien adsorbierte grippeimpfstoffe
|
JP5566687B2
(ja)
*
|
2006-06-15 |
2014-08-06 |
ノバルティス アーゲー |
アジュバントを使用しない複数回投与ワクチン接種レジメン
|
EP3456348A1
(de)
*
|
2006-09-11 |
2019-03-20 |
Seqirus UK Limited |
Herstellung von influenza-virus-impfstoffen ohne verwendung von eiern
|
PE20090146A1
(es)
|
2007-04-20 |
2009-03-23 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica contra el virus influenza
|
US8506966B2
(en)
*
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
NZ600323A
(en)
*
|
2009-12-03 |
2013-12-20 |
Novartis Ag |
Circulation of components during microfluidization and/or homogenization emulsions
|